<DOC>
	<DOCNO>NCT00571558</DOCNO>
	<brief_summary>This phase I trial study side effect best dose photodynamic therapy use aminolevulinic acid treat patient oral leukoplakia . Photodynamic therapy use drug , aminolevulinic acid , become active expose certain kind light . When drug active , abnormal cell kill . Photodynamic therapy use aminolevulinic acid may effective oral leukoplakia .</brief_summary>
	<brief_title>Photodynamic Therapy Using Aminolevulinic Acid Treating Patients With Oral Leukoplakia</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine toxicity feasibility photodynamic therapy use pulse laser therapy oral aminolevulinic acid treat patient oral leukoplakia . II . To define dose-limiting toxicity maximum tolerate dose photodynamic therapy use pulse laser therapy oral aminolevulinic acid patient . SECONDARY OBJECTIVES : I . To assess efficacy photodynamic therapy use pulsed dye laser oral aminolevulinic acid examine clinical response 1 3 month . II . To determine quantitative histologic response 3 month . III . To explore association response specific molecular biologic marker ( i.e. , DNA ploidy , proliferation use Ki-67 , apoptosis use TUNEL , cyclin D1 , p53 ) . OUTLINE : This dose-escalation study long pulse dye laser light . Patients receive aminolevulinic acid* orally ( PO ) 3-4 hour undergo photodynamic therapy use pulsed dye laser day 1 . ( Note : *Patients cohort 1 latter cohort [ determine course study ] receive aminolevulinic acid photodynamic therapy . ) Patients undergo biopsy target lesion clinically uninvolved mucosa 4-8 week begin therapy 3 month biomarker study ( DNA ploidy , p53 , Ki-67 , cyclin D1 , TUNEL assay ) . Blood collect day 1 , 2 , 14 , 28 , 84 toxicity assessment . After completion study treatment , patient follow 84 day .</detailed_description>
	<mesh_term>Leukoplakia , Oral</mesh_term>
	<mesh_term>Leukoplakia</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>Criteria : Histologically confirm oral leukoplakia dysplasia OR oral leukoplakia hyperplasia highrisk area ( e.g. , floor mouth , tongue , oropharynx ) Multiple oral leukoplakia lesion allow however 5 distinct lesion biopsied treat All lesion treat must technically accessible laser Patients oral leukoplakia hyperplasia nonhighrisk location ( e.g. , buccal mucosa illfitting denture ) allow Must willing undergo baseline biopsy leukoplakia lesion ( ) surround normal tissue 48 week therapy repeat biopsy 3 month No evidence ongoing radiation damage target site Karnofsky performance status ( PS ) 70100 % Zubrod PS 01 Life expectancy &gt; 2 year Hemoglobin &gt; 12 g/dL Platelet count &gt; 100,000/mm^3 ANC &gt; 1,500/mm^3 Creatinine = &lt; 1.5 mg/dL SGPT SGOT = &lt; 1.5 x upper limit normal ( ULN ) Total bilirubin = &lt; 1.5 x ULN ( high level bilirubin due familial metabolism consider individual basis ) Willing adhere avoidance sunlight indoor light exposure 24 hour treatment Not pregnant nursing No history allergic reaction attribute compound similar chemical biological composition aminolevulinic acid No porphyria No uncontrolled intercurrent illness include , limited , follow : Ongoing active infection Symptomatic congestive heart failure Unstable angina pectoris Cardiac arrhythmia Psychiatric illness social situation , opinion investigator , would limit compliance jeopardize patient integrity data Prior treatment leukoplakia allow No prior photodynamic therapy More 3 month since prior participation clinical trial leukoplakia More 4 week since prior ablative therapy target lesion More 4 week since prior concurrent psoralen PUVA therapy No concurrent oral retinoids ( e.g. , isotretinoin ) No concurrent use tan bed No concurrent investigational agent Fertile patient must use effective contraception Patients previous diagnosis stage I II head neck cancer eligible provide definitive therapy , include radiation therapy , complete patient render disease free &gt; = 2 year No chronic liver disease include normal liver function test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>